Faculty of Medicine awarded over $590,000 in NSERC Discovery Grants

Faculty of Medicine
Research and Innovation
Research and innovation
Awards and recognition
Geometric medical infographic
The Faculty is excited to announce the Discovery Grants Program and the Discovery Launch Supplement of the Natural Sciences and Engineering Research Council of Canada (NSERC) have granted more than $590,000 to 12 researchers from the Faculty of Medicine to support their innovative research projects.

The Discovery Grants program supports ongoing programs of research with long-term goals and recognizes the creativity and innovation that are at the heart of all research advances. The Discovery Launch Supplement is an additional fund awarded to all Early Career Researchers who are recipients of their first Discovery Grant.

Congratulations to all Investigators who were awarded!

  • Dr. Tommy Alain (CHEO/BMI) - “Molecular Mechanisms of Translation Control for Viral-Delivered Transgenes”
  • Dr. Zakia Dajaoud (CHEO/BMI) - “Deciphering the role of Killer cell Immunoglobulin-like Receptors in gamma delta T Cell immunity”
  • Dr. Daniel Figeys (Pharm) - “Metaproteomics technologies for microbiome analysis”
  • Dr. Patrick Giguere (BMI) - “Development of bifunctional scaffolds for alternative multitarget opioid/non-opioid pharmacotherapy”
  • Dr. Arvind Mer (BMI) - “Machine Learning Framework for Inferring Isoform Functions”
  • Dr. Benjamin Rotstein (UOHI/BMI) - “Rapid discovery of molecular tracers through convergent carbon dioxide fixation chemistry”
  • Dr. Leonard Maler (CMM) - “Quantifying stimulus-evoked activity patterns in a recurrent neural network”
  • Dr. Richard Naud (CMM) - “Dendrocentric learning algorithms for neuromorphic computing”
  • Dr. Armen Saghatelyan (CMM) - “Functional interrogation and behavioral implication of olfactory bulb interneurons born at distinct developmental stages.”
  • Dr. Christopher Gravel (SEPH) - “Signal detection under partial identification for spontaneously reported adverse outcome data”
  • Dr. Mario Tiberi (CMM) - “Proteomic and Signaling Modalities of Dopamine D3 Receptor Polymorphic Variants”